BioSpace News Archive

Paratek Pharmaceuticals, Inc. announced that on February 28, 2022, the Company granted stock options and restricted stock units to six new employees of the Company.

Turning Point Therapeutics, Inc. announced that President and CEO Athena Countouriotis, M.D., will participate in a fireside chat at the 42nd Annual Cowen Healthcare Conference.

Recro Pharma, Inc. today reported financial results for the fourth quarter and year ended December 31, 2021.

Berkshire Biomedical Corporation (“Berkshire” or the “Company”), focused on developing its proprietary drug dispensing technology to enhance patient wellness, announced today that John Timberlake, Chief Executive Officer, will present at the third annual Life Science Intelligence (LSI) USA ’22 Emerging Medtech Summit on March 17, 2022 at 2:55 pm PT.

Avid Bioservices, Inc. (NASDAQ:CDMO), today announced that it will report financial results for the third quarter of fiscal year 2022 on March 8, 2022 after market close and will host a conference call and webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).